Literature DB >> 18816264

Amino-terminal pro-brain natriuretic peptid in prediction of left ventricular ejection fraction.

Mugdim Bajrić1, Fahir Baraković, Zumreta Kusljugić, Nermin Salkić, Elmir Jahić, Mensura Ascerić, Farid Ljuca, Denis Mrsić, Elnur Smajić, Jasmin Caluk, Ramiz Hajrić.   

Abstract

We aimed to evaluate levels of amino-terminal pro-brain natriuretic peptid (NT-proBNP) in prediction of left ventricular ejection fraction (LVEF) in heart failure patients. Prospective study on 60 consecutive patients with symptoms and signs of heart failure was performed. Blood samples for NT-proBNP analysis was taken from all test subjects and echocardiography was also done in all of them. According to LVEF value, patients were divided into four groups; those with <or=30%, 31 to 39%, 40 to 49% and >or=50%. NT-proBNP values correlated with LVEF value. Regression analysis was used to evaluate how well NT-proBNP values predict LVEF. We used Receiver Operating Characteristic Curve calculation to evaluate diagnostic performance of NT-proBNP in estimation of LVEF. Average value of NT-proBNP in test group was 3191.69+/-642.89 pg/ml (p<0.001). Average value of NT-proBNP decreased with higher LVEF categories with significant (p<0.001) and high negative correlation (r= -0,75). Stepwise multivariate linear regression analysis showed that logarithmic value of NT-proBNP was excellent predictor of LVEF value (p<0.05). Model equation based on regression analysis was LVEF=88.645-15.311 x log (NT-proBNP). Predictive model for LVEF yielded from regression analysis had sensitivities of 98% and 81%, specificities of 20% and 90%, positive predictive values of 86% and 78% and negative predictive values of 67% and 92% for predicting patients with LVEF<50% and LVEF<40%, respectively. There was negative linear correlation between NT-proBNP and LVEF. NT-proBNP was excellent predictor of LVEF value (p<0.05).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18816264      PMCID: PMC5694683          DOI: 10.17305/bjbms.2008.2934

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  20 in total

1.  The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.

Authors:  Carsten Tschöpe; Mario Kasner; Dirk Westermann; Regina Gaub; Wolfgang C Poller; Heinz-Peter Schultheiss
Journal:  Eur Heart J       Date:  2005-07-13       Impact factor: 29.983

2.  Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.

Authors:  T Mueller; A Gegenhuber; W Poelz; M Haltmayer
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

3.  Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction.

Authors:  A P Davie; C M Francis; M P Love; L Caruana; I R Starkey; T R Shaw; G R Sutherland; J J McMurray
Journal:  BMJ       Date:  1996-01-27

4.  The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

Authors:  James L Januzzi; Carlos A Camargo; Saif Anwaruddin; Aaron L Baggish; Annabel A Chen; Daniel G Krauser; Roderick Tung; Renee Cameron; J Tobias Nagurney; Claudia U Chae; Donald M Lloyd-Jones; David F Brown; Stacy Foran-Melanson; Patrick M Sluss; Elizabeth Lee-Lewandrowski; Kent B Lewandrowski
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

5.  The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.

Authors:  Rhidian J Shelton; Andrew L Clark; Kevin Goode; Alan S Rigby; John G F Cleland
Journal:  Eur Heart J       Date:  2006-09-04       Impact factor: 29.983

6.  Plasma brain natriuretic peptide concentration: impact of age and gender.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

7.  Utility of N-terminal pro-brain natriuretic peptide for the diagnosis of heart failure.

Authors:  Jacob V Jose; Satya N Gupta; Dhayakani Selvakumar
Journal:  Indian Heart J       Date:  2003 Jan-Feb

8.  Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

9.  Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population.

Authors:  B A Groenning; I Raymond; P R Hildebrandt; J C Nilsson; M Baumann; F Pedersen
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

10.  NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.

Authors:  M Bay; V Kirk; J Parner; C Hassager; H Nielsen; K Krogsgaard; J Trawinski; S Boesgaard; J Aldershvile
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.